leucemia | sciencenewsnet.in

Breaking News

Technological Breakthrough in Carbon Nanotube Applications for Battery Dry Process

Lack of control at work identified as cause for physician burnout and attrition

Expanding HPV vaccination to all adults aged 27-45 years unlikely to be cost-effective or efficient for HPV-related cancer prevention

University Student’s Start-Up Expands, Connecting Small Coffee Farmers to the World

FSU physicists will study nuclear reactions of stars with support from National Science Foundation

Warning: don’t miss Thanksgiving dinner, it’s more meaningful than you think

Roswell Park Launches First-of-Its-Kind Oncology Training Program for Nurse-Scientists With $2M NCI Grant

UT Southwestern brings first-of-its-kind radiation oncology to new $177M campus in Fort Worth Medical District

Tips and recipes for a healthy holiday season from a doctor and a dietitian

X-ray Measurements Reveal an Unexpected Role for Copper in Photocatalysts

26 Nov, 2024

Cinco avances clave en los trasplantes de médula ósea

November 1, 2022 sarah JonasFeature

En las seis décadas posteriores a que se comience a utilizar el trasplante de médula para tratar a pacientes con distintos tipos de cáncer de la sangre, este tratamiento, que en un principio fue experimental, se ha vuelto una herramienta vital para la lucha contra el cáncer. Mayo Clinic de Rochester (Minnesota) celebra el trasplante de sangre y médula ósea número 10 000 utilizado en el tratamiento de distintos tipos de cáncer de la sangre y trastornos relacionados.